Ceribell Inc (CBLL): Next-Year EPS Estimate 32.83%
As of 2026-06-11, Ceribell Inc (CBLL) has a next-year EPS growth estimate of 32.83%.
On 2026-05-17, analyst consensus for CBLL's next-year EPS growth shifted from 32.33% to 32.83% — a positive change of 0.50 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at -16.92%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 32.83%
- EPS growth this year
- -16.92%
- EPS next quarter (est)
- -$0.47
- Last price
- $18.15
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 32.83% | -16.92% | -$0.47 | $18.15 |
| 2026-06-10 | 32.83% | -16.92% | -$0.47 | $18.38 |
| 2026-06-09 | 32.83% | -16.92% | -$0.47 | $18.50 |
| 2026-06-08 | 32.83% | -16.92% | -$0.47 | $18.14 |
| 2026-06-07 | 32.83% | -16.92% | -$0.47 | $18.25 |
| 2026-06-04 | 32.83% | -16.92% | -$0.47 | $18.75 |
| 2026-06-03 | 32.83% | -16.92% | -$0.47 | $17.18 |
| 2026-06-02 | 32.83% | -16.92% | -$0.47 | $17.50 |
| 2026-06-01 | 32.83% | -16.92% | -$0.47 | $17.61 |
| 2026-05-31 | 32.83% | -16.92% | -$0.47 | $18.45 |
| 2026-05-28 | 32.83% | -16.92% | -$0.47 | $18.67 |
| 2026-05-27 | 32.83% | -16.92% | -$0.47 | $18.70 |
| 2026-05-26 | 32.83% | -16.92% | -$0.47 | $18.80 |
| 2026-05-25 | 32.83% | -16.92% | -$0.47 | $18.77 |
| 2026-05-24 | 32.83% | -16.92% | -$0.47 | $18.77 |
| 2026-05-21 | 32.83% | -16.92% | -$0.47 | $18.74 |
| 2026-05-20 | 32.83% | -16.92% | -$0.47 | $18.10 |
| 2026-05-19 | 32.83% | -16.92% | -$0.47 | $16.96 |
| 2026-05-18 | 32.83% | -16.92% | -$0.47 | $16.58 |
| 2026-05-17 | 32.83% | -16.92% | -$0.47 | $16.30 |
| 2026-05-14 | 32.33% | -16.32% | -$0.47 | $16.46 |
| 2026-05-13 | 32.33% | -16.32% | -$0.47 | $17.50 |
| 2026-05-12 | 32.33% | -16.32% | -$0.47 | $16.75 |
| 2026-05-11 | 30.88% | 0.26% | -$0.39 | $20.06 |
| 2026-05-10 | 30.88% | 0.26% | -$0.39 | $20.20 |
| 2026-05-07 | 30.88% | 0.26% | -$0.39 | $20.38 |
| 2026-05-06 | 30.88% | 0.26% | -$0.39 | $20.15 |
| 2026-05-05 | 30.88% | 0.26% | -$0.39 | $20.37 |
| 2026-05-04 | 30.88% | 0.26% | -$0.39 | $20.27 |
| 2026-05-03 | 30.88% | 0.26% | -$0.39 | $20.50 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ceribell Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Ceribell Inc (CBLL) has a next-year EPS growth estimate of 32.83%, based on analyst consensus.
When was the latest EPS estimate revision for CBLL?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 32.33% to 32.83%.
What sector and industry does Ceribell Inc belong to?▾
Ceribell Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CBLL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ceribell Inc (CBLL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports